Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page's revision label changed from Revision: v3.6.6 to Revision: v3.7.0, indicating a software update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check37 days agoChange DetectedFooter revision label updated from v3.6.5 to v3.6.6. This indicates a minor software update to the site interface.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.6.5 replaces the previous v3.6.4, updating the page's displayed site revision. This signals a new build/version of the ClinicalTrials.gov interface without altering the underlying study records.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page history now shows the latest revision as v3.6.4, replacing the previous v3.6.3, indicating the record has been updated to a newer version. No study data or public content changes are reflected in this entry.SummaryDifference0.0%

- Check94 days agoChange DetectedThe page footer now shows Revision: v3.6.3, indicating a newer build was deployed; the previous Revision: v3.6.2 is no longer displayed.SummaryDifference0.0%

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.